14 series
Export
<<<Page of 1 >>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterSRA Run Selector Remove filterJoanna Achinger-Kawecka
GSE73782
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [Hi-C]
13 Joanna Achinger-Kawecka Apr 04, 2016
GSE73783
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [ChIP-seq]
3 Joanna Achinger-Kawecka Apr 04, 2016
GSE73784
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq]
6 Joanna Achinger-Kawecka Apr 04, 2016
GSE118711
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [ChIP-seq]
14
  • Download icon BB
  • Download icon SRA Run Selector
Joanna Achinger-Kawecka Dec 11, 2019
GSE118712
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [Hi-C]
9 Joanna Achinger-Kawecka Dec 11, 2019
GSE118713
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq]
9 Joanna Achinger-Kawecka Dec 11, 2019
GSE118714
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [WGBS]
3 Joanna Achinger-Kawecka Dec 11, 2019
GSE118715
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [WGS]
5 Joanna Achinger-Kawecka Dec 11, 2019
GSE130916
Deregulation of the three-dimensional epigenome in endocrine resistant breast cancer
6 Joanna Achinger-Kawecka Dec 11, 2019
GSE150252
BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer
12 Joanna Achinger-Kawecka Feb 10, 2021
GSE171070
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [ChIP-seq]
23 Joanna Achinger-Kawecka Dec 12, 2021
GSE171071
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [HiC]
6 Joanna Achinger-Kawecka Dec 12, 2021
GSE171072
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [PCHiC]
6 Joanna Achinger-Kawecka Dec 12, 2021
GSE171073
Epigenetic therapy suppresses tumour growth by rewiring ER-mediated long-range chromatin interactions in ER+ endocrine-resistant breast cancer [RNA-seq]
16 Joanna Achinger-Kawecka Dec 12, 2021